Construction of KEB’s 2,000 t/a stevioside processing project starts

At the end of Aug. 2017, Inner Mongolia Ever Brilliance Biotechnology Co., Ltd. (KEB) announced that its 2,000 t/a stevioside processing project, with a total investment of USD22.76 million (RMB150 million), began to be built in Kailu County, Inner M...

More from CCM

www.cnchemicals.com